Announced Sat, 1 Aug · 13:50 IST
Orchid Pharma allots 4.46 cr shares to Dhanuka Labs shareholders
ORCHPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.4%1-day move
₹987.30
prior close
₹990.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.1-0.4-0.1-1.1+0.4+0.6+0.3+1.9+9.9+7.9+5.2-4.6——
Up moveDown movePending
AI summary
Orchid Pharma's Board approved allotment of 4,45,86,052 equity shares of Rs 10 each to eligible shareholders of Dhanuka Laboratories under the amalgamation scheme that became effective on July 10, 2026. Record date was July 23, 2026. Post-allotment, paid up share capital stands at about Rs 59.88 crore divided into 5.98 crore shares, with new shares to rank equally with existing ones and list on BSE and NSE. Cross holding of Dhanuka Labs was also cancelled.
Likely market impact
Significant dilution for existing Orchid Pharma shareholders as 4.46 crore new shares nearly triple the share count. Watch for price adjustment after listing.